arsenic trioxide has been researched along with Pericardial Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hangaishi, A; Ichikawa, M; Kaise, T; Kumano, K; Kurokawa, M; Miyashita, SI; Nagai, S; Nannya, Y; Ueda, K | 1 |
| Antonioli, E; Cas, LD; D'Aloia, A; Raddino, R; Vizzardi, E; Zanini, G | 1 |
2 other study(ies) available for arsenic trioxide and Pericardial Effusion
| Article | Year |
|---|---|
Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome.
Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Pericardial Effusion; Pleural Effusion | 2010 |
QT prolongation: a case of arsenical pericardial and pleural effusion.
Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Long QT Syndrome; Male; Oxides; Pericardial Effusion; Pleural Effusion; Recovery of Function; Withholding Treatment | 2008 |